Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug. This strategic alliance leverages the unique capabilities of TNL’s AI Digital Cells...
ConcertAI and Caris Life Sciences (Caris) announced a multi-year partnership to support AbbVie's precision medicine-driven research and development efforts, and clinical trial optimization in oncology.
The agreement will allow AbbVie to leverage Caris' expansive real-world, multi-modal database in oncology and ConcertAI's collection of research-grade clinical data across a wide range...
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, announced the release of a groundbreaking product developed from Paige’s Pathology Foundation Model, Virchow. Built using one of the largest libraries of digitized images, utilizing unique computational resources provided by Microsoft Research, Paige has developed the first...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this new role, which begins in February, Dr. Rothenberg will lead all aspects of clinical development, including strategy on clinical trial design; oversee medical affairs, pharmacovigilance...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences. Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA...
Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies, announced its partnership with Graticule, an on-demand, advanced real-world data and advisory services provider. The two companies are designing research algorithms and real-world data services to better identify and prioritize patients for clinical trials...
Isomorphic Labs, a digital biology company with a mission to redefine drug discovery using the power of artificial intelligence, announced that it has entered into a strategic research collaboration with Novartis to discover small molecule therapeutics against three undisclosed targets.
"Isomorphic Labs and Novartis hold a shared purpose to reimagine...
Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors, and the appointment of Yossi Ben Amram, former Merck & Co., Inc. (MSD) Regional President, as President of Quris-AI.
“Adding accomplished pharmaceutical leaders such as Yossi...
Chicago-based Evozyne announced Marc Yoskowitz as CEO of the generative AI-driven biotech.
Yoskowitz, most recently chief strategy officer and executive vice president, life sciences, at Tempus AI, will further develop the company’s strategy, focusing its generative AI platform on drug discovery in areas of high unmet patient need. Yoskowitz has...
Nanotronics, the Industrial AI company, announced a new strategic partnership with OrbiMed, a leading global life sciences investment firm. As part of the transaction, OrbiMed is investing in Nanotronics’ proprietary technology to advance quality control and precision manufacturing across the healthcare and biotech industries.
“AI is redrawing the healthcare landscape...
